Home

Innovent Receives Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α Bispecific Antibody Fusion Protein) as Monotherapy for Advanced Melanoma

SAN FRANCISCOand SUZHOU,China,Sept. 4,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qua

World NewsSep 4, 2024

Axcelis Announces Sponsorship and Participation in The International Conference on Ion Implantation Technology 2024 in Toyoma, Japan

BEVERLY,Mass.,Sept. 4,2024-- Axcelis Technologies,Inc. (NASDAQ: ACLS),a leading supplier of enabling ion implantation solutions for the semiconductor industry,will be a top-level Platinum Sponsor at

World NewsSep 4, 2024

CNOOC Limited Brings On-stream Wushi 17-2 Oilfields

HONG KONG,Sept. 4,2024-- CNOOC Limited (the "Company",SEHK: 00883 (HKD Counter) and 80883 (RMB Counter),SSE: 600938) announces today that Wushi 17-2 Oilfields Development Project has commen

Lifestyle and EntertainmentSep 4, 2024

IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances

MELBOURNE,Australia,Sept. 4,2024-- Telix Pharmaceuticals Limited (ASX: TLX,Telix,the Company) today announces that the Company\'s IPAX-1 Phase I study has been published in Neuro-Oncology Advances,co

FinanceSep 4, 2024

AV-Comparatives Identifies Key Cybersecurity Threats for Summer 2024: Fakeshops, Phishing Attacks and Targeting Children

Unveiling the Rise of Counterfeit Retail Platforms,SophisticatedPhishing Schemes,and Increasing Cyber Risks for Minors in Summer 2024

FinanceSep 4, 2024

Goodnotes Tours 50 American Colleges to Introduce Students to AI-Enhanced Note-taking & Learning

With AI tools proliferating campuses,Goodnotes will showcase how its AI-powered digital paper can enhance—rather than supplant—student studying,learning,and thinking

Tech&ScienceSep 4, 2024

Acepodia Enters Strategic Clinical Collaboration with Pfizer to Accelerate Development of Antibody-Cell Conjugation-Based Cell Therapies in Autoimmune Diseases

Through Pfizer Ignite,Acepodia will gain access to Pfizer\'s resources,scale and expertise as the company broadens the application of its platform beyond oncology into autoimmune diseases

BusinessSep 4, 2024

Nature's Miracle Announces Participation in the H.C. Wainwright Annual Global Investment Conference

ONTARIO,Calif.,Sept. 4,2024-- Nature\'s Miracle Holding Inc. (NASDAQ: NMHI) ("Nature\'s Miracle" or the "Company"),a leader in vertical farming technology and infrastructure,today

AISep 4, 2024

SurplusGLOBAL at SEMICON TAIWAN 2024 with Strengthened Team and New Opportunities

SEOUL,South Korea,Sept. 4,2024-- SurplusGLOBAL,a global leader in the legacy semiconductor equipment market,is pleased to announce its participation in SEMICON TAIWAN 2024,which will be held from Sep

SportsSep 4, 2024

Frost Radar™ Positions 14 Top Growth & Innovation Leaders in Global Healthcare Data Interoperability

Frost & Sullivan\'s Benchmarking System Highlights Leading Companies Poised for Growth and Advancing Healthcare Interoperability

BusinessSep 4, 2024

1 ... 1071 1072 1073 1074 1075 1076 1077 ... 1250

English Morning News： a global comprehensive News Website in Europe and the United States. The site focuses on reporting public affairs, regional news and corporate news and announcements, which provides the public with comprehensive and inclusive information.

Navigation

Quick Search

English Morning News: Your Source for Regional News and Corporate

Category :